Evidence map›Paper›PMID 38937583›Full record

ArticleNature neuroscience2024

T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis.

Shreeya Kedia, Hao Ji, Ruoqing Feng, Peter Androvic, Lena Spieth, Lu Liu, Jonas Franz, Hanna Zdiarstek, Katrin Perez Anderson, Cem Kaboglu and 11 more

Erratum issuedAbstract read
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. A computational roadmap to activity-dependent myelination.Frontiers in computational neuroscience · 2026
    Article
  16. Review
  17. Review
  18. Interleukin-6, CD8Frontiers in aging neuroscience · 2026
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Shreeya Kedia *Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Hao Ji *Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Ruoqing FengInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Peter AndrovicInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Lena SpiethInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Lu LiuInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-6233-0705
Jonas FranzDepartment of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0001-7523-6622
Hanna ZdiarstekDepartment of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0009-0009-1341-3107
Katrin Perez AndersonInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Cem KabogluInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7887-1602
Qian LiuInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.
Nicola MattuginiInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Fatma CherifGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Danilo PrtvarGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID http://orcid.org/0009-0004-8251-1441
Ludovico Cantuti-CastelvetriInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-0642-1610
Arthur LieszInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-9069-2594
Martina SchiffererGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID http://orcid.org/0000-0002-0500-8218
Christine StadelmannDepartment of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0003-1766-5458
Sabina TahirovicGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.ORCID http://orcid.org/0000-0003-4403-9559
Ozgun GokceInstitute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-6319-404X
Mikael SimonsInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany. mikael.simons@dzne.de.ORCID http://orcid.org/0000-0001-5329-192X

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) ERC Adv Grant
6 · The paper itself

Abstract

Age-related myelin damage induces inflammatory responses, yet its involvement in Alzheimer's disease remains uncertain, despite age being a major risk factor. Using a mouse model of Alzheimer's disease, we found that amyloidosis itself triggers age-related oligodendrocyte and myelin damage. Mechanistically, CD8

Indexed as

Alzheimer DiseaseAmyloidosisDisease Models, AnimalMicrogliaMyelin SheathAnimalsCD8-Positive T-LymphocytesMiceMice, Inbred C57BLMice, TransgenicOligodendroglia

Identifiers

PMID38937583
PMCPMC11303250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.